Koers Achieve Life Sciences Inc Nasdaq
Aandelen
US0044681049
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 171 mln. 158 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -34 mln. -31,29 mln. | Nettowinst (verlies) 2025 * | -39 mln. -35,89 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,52
x | K/w-verhouding 2025 * |
-5,25
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,62% |
Recentste transcriptie over Achieve Life Sciences Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 01-08-14 |
Richard Stewart
CHM | Chairman | 65 | 01-05-15 |
Cindy Jacobs
PSD | President | 66 | 01-08-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 14-03-22 |
Thomas King
BRD | Director/Board Member | 69 | 29-03-23 |
Cindy Jacobs
PSD | President | 66 | 01-08-08 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,09% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-4,96% | 29,18 mld. | |
+11,18% | 26,02 mld. | |
-21,95% | 18,9 mld. | |
+8,61% | 13,21 mld. | |
+24,73% | 12,17 mld. | |
+28,31% | 12,16 mld. | |
-6,26% | 11,42 mld. |